# ARS Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Jul 2, 2025

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: SCHEDULE 13D/A
- Filed: 2025-07-02
- Accepted by EDGAR: Jul 2, 2025, 08:24 ET
- Period: not reported
- Accession: 0001193805-25-000963
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119380525000963/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119380525000963/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119380525000963/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jul 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001193805-25-000963. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
